BIO KEY INTERNATIONAL INCBKYIEarnings & Financial Report
Nasdaq
NextApr 23, 2026
BKYI Q3 2025 Key Financial Metrics
Revenue
$1.5M
Gross Profit
$1.2M
Operating Profit
$-892.2K
Net Profit
$-964.8K
Gross Margin
76.9%
Operating Margin
-57.6%
Net Margin
-62.3%
YoY Growth
-27.7%
EPS
$-0.15
Financial Flow
BIO KEY INTERNATIONAL INC Q3 2025 Financial Summary
BIO KEY INTERNATIONAL INC reported revenue of $1.5M for Q3 2025, with a net profit of $-964.8K (-62.3% margin). Cost of goods sold was $358.0K, operating expenses totaled $2.1M.
Key Financial Metrics
| Total Revenue | $1.5M |
|---|---|
| Net Profit | $-964.8K |
| Gross Margin | 76.9% |
| Operating Margin | -57.6% |
| Report Period | Q3 2025 |
BIO KEY INTERNATIONAL INC Annual Revenue by Year
BIO KEY INTERNATIONAL INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $6.9M).
| Year | Annual Revenue |
|---|---|
| 2024 | $6.9M |
| 2023 | $7.8M |
| 2022 | $7.0M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $925101 | $2.2M | $1.1M | $2.1M | $1.5M | $1.6M | $1.7M | $1.5M |
| YoY Growth | -47.4% | -29.3% | -40.8% | 18.0% | 58.1% | -26.3% | 48.7% | -27.7% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.5M | $4.2M | $4.8M | $6.4M | $8.6M | $11.2M | $10.5M | $10.1M |
| Liabilities | $3.5M | $3.6M | $5.9M | $6.3M | $4.8M | $3.7M | $3.7M | $4.1M |
| Equity | $1.1M | $535728 | $-1.1M | $133042 | $3.8M | $7.5M | $6.9M | $6.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.5M | $297084 | $-1.4M | $-1.3M | $-514564 | $-835312 | $-880012 | $-1.1M |